ConductScience.org, home

Paper39633593

TMB is associated with the prognosis of egfr-mutated non-small cell lung cancer in Xuanwei, China.

Wang H and 6 others. Biomark Med, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. TMB is associated with the prognosis of egfr-mutated non-small cell lung cancer in Xuanwei, China. Papers, record 39633593. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39633593

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
TMB is associated with the prognosis of egfr-mutated non-small cell lung cancer in Xuanwei, China.
PubMed
Journal
Biomark Med
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.29, provisional
iCite
Revised in PubMed
2026-07-07
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang HHan
2Ma JJunrui
3Lu JJiagui
4Wang YYang
5Zhang BBinli
6Zhang HHushanhttps://orcid.org/0000-0002-7557-4426
7Peng HHao

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
ErbB ReceptorsMajor topic
Lung NeoplasmsMajor topic
MutationMajor topic
Humans
Female
Male
China
Middle Aged
Prognosis
Retrospective Studies
Aged
Biomarkers, Tumor
Adult

Source PubMed

Download CSV of topics

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133796457The Association of microRNA-34a With High Incidence and Metastasis of Lung Cancer in Gejiu and Xuanwei Yunnan.Front Oncol2021https://conductscience.org/library/papers/33796457PubMed
234406546Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy.Gastric Cancer2021https://conductscience.org/library/papers/34406546PubMed
333224870Distinct EGFR Mutation Pattern in Patients With Non-Small Cell Lung Cancer in Xuanwei Region of China: A Systematic Review and Meta-Analysis.Front Oncol2020https://conductscience.org/library/papers/33224870PubMed
431518876The characteristics of lung cancer in Xuanwei County: A review of differentially expressed genes and noncoding RNAs on cell proliferation and migration.Biomed Pharmacother2019https://conductscience.org/library/papers/31518876PubMed
523224416The epidemic status and risk factors of lung cancer in Xuanwei City, Yunnan Province, China.Front Med2012https://conductscience.org/library/papers/23224416PubMed
632945604Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review.Thorac Cancer2020https://conductscience.org/library/papers/32945604PubMed
728882180High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods.J Exp Clin Cancer Res2017https://conductscience.org/library/papers/28882180PubMed
832450353Particle-induced oxidative damage by indoor size-segregated particulate matter from coal-burning homes in the Xuanwei lung cancer epidemic area, Yunnan Province, China.Chemosphere2020https://conductscience.org/library/papers/32450353PubMed
931208370EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer.BMC Cancer2019https://conductscience.org/library/papers/31208370PubMed
1033535978Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.BMC Cancer2021https://conductscience.org/library/papers/33535978PubMed
1130098332Epidermal growth factor receptor: Structure-function informing the design of anticancer therapeutics.Exp Cell Res2018https://conductscience.org/library/papers/30098332PubMed
1234603786Diagnosis and prognosis models for hepatocellular carcinoma patient's management based on tumor mutation burden.J Adv Res2021https://conductscience.org/library/papers/34603786PubMed
1334625620CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer.Sci Rep2021https://conductscience.org/library/papers/34625620PubMed
1425223911Household air pollution and lung cancer in China: a review of studies in Xuanwei.Chin J Cancer2014https://conductscience.org/library/papers/25223911PubMed
1531930049Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.Ann Transl Med2019https://conductscience.org/library/papers/31930049PubMed
1635020204Cancer statistics, 2022.CA Cancer J Clin2022https://conductscience.org/library/papers/35020204PubMed
1712048270Household stove improvement and risk of lung cancer in Xuanwei, China.J Natl Cancer Inst2002https://conductscience.org/library/papers/12048270PubMed
1812650907Mutation spectra of smoky coal combustion emissions in Salmonella reflect the TP53 and KRAS mutations in lung tumors from smoky coal-exposed individuals.Mutat Res2003https://conductscience.org/library/papers/12650907PubMed
1923470965Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.Clin Cancer Res2013https://conductscience.org/library/papers/23470965PubMed
2025435280HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer.Mol Oncol2015https://conductscience.org/library/papers/25435280PubMed

See all 56 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42038348Unveiling the prognostic and immunotherapeutic role of Tregs in lung cancer using integrated analysis of single-cell and bulk RNA-sequencing.Oncol Lett2026https://conductscience.org/library/papers/42038348PubMed
41132967Molecular and clonal evolution of primary lesions vs. brain metastasis in EGFR-mutated NSCLC: a retrospective cohort study.Transl Lung Cancer Res2025https://conductscience.org/library/papers/41132967PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39633593

GET https://conductscience.org/api/papers/v1/39633593/references?page=2